Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN115594648B introduces mild photocatalytic alkylation. Delivers high purity and yield. Offers supply chain reliability and cost reduction for pharmaceutical intermediates manufacturing globally.
Patent CN107011239A reveals water-based Pd-catalyzed synthesis. Offers high yield and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN107935902B reveals a one-step decarboxylative coupling for Vonoprazan intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Novel patent CN117417275A reveals efficient synthesis. Reduces waste, enhances supply chain reliability for pharmaceutical intermediates.
Novel three-step method for Cabazitaxel preparation offering high purity and cost efficiency for pharmaceutical supply chains ensuring reliable anticancer API supplier status.
Patent CN112876403A details a high-yield synthesis of Apremilast EP Impurity C. This route offers cost reduction in API manufacturing and ensures supply chain reliability.
Novel salt recrystallization route for Telmisartan achieving >99.8% purity without high-boiling solvents. Ideal for reliable API supplier partnerships.
Patent CN104803949B reveals a novel HEPES synthesis route eliminating ion exchange resins, ensuring high purity and reduced environmental impact for reliable supply.
Novel silylation route for Tolvaptan offers high purity and yield. Cost-effective industrial process for pharmaceutical intermediates.
Patent CN110467571A details a low-cost synthesis for URAT1 inhibitor intermediates. This method ensures high purity and supply chain stability for global pharmaceutical manufacturing.
Patent CN102746289B reveals a robust crystallization process for Lurasidone Hydrochloride, ensuring high purity and low solvent residue for cost reduction in pharmaceutical manufacturing.
Advanced synthesis of Deuterated Diazepam via patent CN103204819A. Offers high-purity analytical standards with cost-effective deuteration for pharmaceutical quality control.
Patent CN104788335B reveals high-yield imide synthesis. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN103724264A details iridium-catalyzed asymmetric hydrogenation for high-purity chiral tetrahydroisoquinoline derivatives, offering significant cost reduction and supply chain reliability.
Novel oxidation-dehydration route for high-purity intermediate production. Reduces steps and safety risks for global pharmaceutical supply chains significantly and effectively.
Novel patent CN116410244B enables high-yield D-mannose production. Reduces costs and ensures supply continuity for global pharmaceutical intermediate manufacturing partners.
Novel patent CN116410244B details improved D-mannose synthesis yielding 50-60%. Offers cost reduction and supply reliability for PET imaging precursor manufacturing.
Patent CN102260721A details a green enzymatic route for Levetiracetam intermediates, offering significant cost reduction in API manufacturing and superior supply chain reliability.
Novel synthetic route for high-purity pharmaceutical intermediates reduces costs and ensures supply continuity for global drug manufacturers seeking reliable API intermediate partners.
Novel alkylation-cyclization route for brinzolamide key intermediate reduces cost and simplifies supply chain for global API manufacturers.